45793 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Sep 17
13:16 UTC
|
OSCR
Oscar Health
|
◎ Target | Michael Ha ★★★★★ #279 | Neutral | $27.00→ $33.00+22.2% |
|
Sep 17
13:16 UTC
|
OSCR
Oscar Health
|
◎ Target | Andrew Mok not yet tracked | Overweight | $39.00→ $49.00+25.6% |
|
Sep 17
13:16 UTC
|
ONON
ON
|
◎ Target | Thierry Cota not yet tracked | Buy | $46.00→ $43.00-6.5% |
|
Sep 17
13:16 UTC
|
ON
onsemi
|
◎ Target | Joe Quatrochi not yet tracked | Overweight | $95.00→ $85.00-10.5% |
|
Sep 17
13:16 UTC
|
JBHT
J.B. Hunt Transport Services
|
◎ Target | Daniel Moore ★★☆☆☆ #2808 | Outperform | $320.00→ $290.00-9.4% |
|
Sep 17
13:16 UTC
|
IOVA
Iovance Biotherapeutics
|
◎ Target | Etzer Darout ★★★☆☆ #1235 | Overweight | $13.00→ $15.00+15.4% |
|
Sep 17
13:16 UTC
|
FLNC
Fluence Energy
|
◎ Target | Ameet Thakkar ★★☆☆☆ #2285 | Market Perform | $14.00→ $7.00-50.0% |
|
Sep 17
13:16 UTC
|
ENVA
Enova International
|
◎ Target | Kyle Joseph ★★☆☆☆ #2855 | Overweight | $275.00→ $205.00-25.5% |
|
Sep 17
13:16 UTC
|
ELF
e.l.f. Beauty
|
◎ Target | Cristian Rios not yet tracked | Outperform | $121.00→ $127.00+5.0% |
|
Sep 17
13:16 UTC
|
CRM
Salesforce
|
◎ Target | John DiFucci ★★★★★ #49 | Buy | $270.00→ $300.00+11.1% |
|
Sep 17
13:16 UTC
|
CRM
Salesforce
|
◎ Target | Keith Bachman ★★★★★ #122 | Outperform | $250.00→ $285.00+14.0% |
|
Sep 17
13:16 UTC
|
APPF
AppFolio
|
◎ Target | Jason Celino ★★★★★ #263 | Overweight | $255.00→ $280.00+9.8% |
|
Sep 17
13:16 UTC
|
AMRX
Amneal Pharmaceuticals
|
◎ Target | Glen Santangelo ★★★★☆ #856 | Overweight | $16.00→ $20.00+25.0% |
|
Sep 17
13:16 UTC
|
AHCO
AdaptHealth
|
◎ Target | Eric Coldwell ★★★★☆ #437 | Outperform | $10.00→ $9.00-10.0% |
|
Sep 17
13:16 UTC
|
LYFT
Lyft
|
↓ Downgrade | Taylor Manley not yet tracked | Buy→ Neutral | $22.00→ $16.00-27.3% |
|
Sep 17
13:16 UTC
|
FLNC
Fluence Energy
|
↓ Downgrade | Brian Lee not yet tracked | Buy→ Neutral | $9.00 |
|
Sep 17
13:16 UTC
|
BSX
Boston Scientific
|
↓ Downgrade | Joanne Wuensch ★★★★☆ #433 | Buy→ Neutral | $50.00 |
|
Sep 17
13:16 UTC
|
JBHT
J.B. Hunt Transport Services
|
↑ Upgrade | Jeff Kauffman ★★★☆☆ #1372 | Market Perform→ Outperform | $300.00 |
|
Sep 17
12:16 UTC
|
ON
onsemi
|
◎ Target | Matthew Prisco ★★☆☆☆ #2502 | Neutral | $110.00→ $90.00-18.2% |
|
Sep 17
12:16 UTC
|
OKTA
Okta
|
◎ Target | Gray Powell ★★★★★ #14 | Buy | $187.00→ $219.00+17.1% |
|
Sep 17
12:16 UTC
|
GNRC
Generac
|
◎ Target | George Gianarikas ★☆☆☆☆ #3214 | Buy | $275.00→ $375.00+36.4% |
|
Sep 17
12:16 UTC
|
FLNC
Fluence Energy
|
◎ Target | George Gianarikas ★☆☆☆☆ #3214 | Buy | $24.00→ $15.00-37.5% |
|
Sep 17
12:16 UTC
|
CRM
Salesforce
|
◎ Target | David Hynes ★★★★★ #120 | Buy | $270.00→ $300.00+11.1% |
|
Sep 17
12:16 UTC
|
CIEN
Ciena
|
◎ Target | Meta Marshall ★★★★☆ #723 | Equal Weight | $425.00→ $450.00+5.9% |
|
Sep 17
12:16 UTC
|
S
SentinelOne
|
↓ Downgrade | Peter Weed ★★★★★ #4 | Outperform→ Market Perform | $21.00→ $25.00+19.0% |
|
Sep 17
12:16 UTC
|
PANW
Palo Alto Networks
|
↓ Downgrade | Peter Weed ★★★★★ #4 | Outperform→ Market Perform | $253.00→ $351.00+38.7% |
|
Sep 17
12:16 UTC
|
OKTA
Okta
|
↓ Downgrade | Peter Weed ★★★★★ #4 | Outperform→ Market Perform | $143.00→ $174.00+21.7% |
|
Sep 17
12:16 UTC
|
LYFT
Lyft
|
↓ Downgrade | firm only | Buy→ Neutral | |
|
Sep 17
12:16 UTC
|
HAWK
HawkEye 360
|
↑ Upgrade | Ronald Epstein ★★☆☆☆ #2824 | Neutral→ Buy | $34.00→ $23.00-32.4% |
|
Sep 17
11:16 UTC
|
BSX
Boston Scientific
|
↓ Downgrade | Joanne Wuensch ★★★★☆ #433 | Buy→ Neutral | |
|
Sep 17
11:16 UTC
|
ADSK
Autodesk
|
↑ Upgrade | Matthew Martino ★★★★★ #143 | Neutral→ Outperform | $265.00 |
|
Sep 17
10:16 UTC
|
TRTX
TPG RE Finance Trust
|
↓ Downgrade | firm only | Neutral | |
|
Sep 17
10:16 UTC
|
KGFHY
Kingfisher
|
↑ Upgrade | firm only | Sell→ Hold | |
|
Sep 17
10:16 UTC
|
JBHT
J.B. Hunt Transport Services
|
↑ Upgrade | Ariel Rosa ★★★☆☆ #1114 | Market Perform→ Outperform | |
|
Sep 17
10:16 UTC
|
ADSK
Autodesk
|
↑ Upgrade | Matthew Martino ★★★★★ #143 | Neutral→ Outperform | |
|
Sep 17
09:16 UTC
|
ZEG
Zegona Communications
|
◎ Target | firm only | Buy | GBX 2,500→ GBX 2,450-2.0% |
|
Sep 17
09:16 UTC
|
TBTG
The Beauty Tech Group
|
◎ Target | firm only | Buy | GBX 550→ GBX 600+9.1% |
|
Sep 17
09:16 UTC
|
SSE
SSE
|
◎ Target | firm only | Buy | GBX 2,800→ GBX 2,980+6.4% |
|
Sep 17
09:16 UTC
|
SMWH
WH Smith
|
◎ Target | firm only | Overweight | GBX 575→ GBX 550-4.3% |
|
Sep 17
09:16 UTC
|
SMWH
WH Smith
|
◎ Target | firm only | Hold | GBX 420→ GBX 440+4.8% |
|
Sep 17
09:16 UTC
|
GFRD
Galliford Try
|
◎ Target | firm only | Buy | GBX 680→ GBX 750+10.3% |
|
Sep 17
09:16 UTC
|
AT
Ashtead Technology
|
◎ Target | firm only | Buy | GBX 600→ GBX 500-16.7% |
|
Sep 17
09:16 UTC
|
ACG
ACG Acquisition
|
◎ Target | firm only | Buy | GBX 2,370→ GBX 2,295-3.2% |
|
Sep 17
09:16 UTC
|
GNRC
Generac
|
↓ Downgrade | firm only | Hold | $333.00 |
|
Sep 17
00:15 UTC
|
YUM
Yum! Brands
|
◎ Target | Chris O'Cull not yet tracked | Outperform | $174.00→ $165.00-5.2% |
|
Sep 17
00:15 UTC
|
XPOF
Xponential Fitness
|
◎ Target | Arpine Kocharyan ★★★☆☆ #1262 | Neutral | $7.00→ $4.50-35.7% |
|
Sep 17
00:15 UTC
|
WTW
Willis Towers Watson Public
|
◎ Target | Yaron Kinar ★★★★★ #223 | Outperform | $406.00→ $380.00-6.4% |
|
Sep 17
00:15 UTC
|
WRB
W.R. Berkley
|
◎ Target | Yaron Kinar ★★★★★ #223 | Neutral | $74.00→ $72.00-2.7% |
|
Sep 17
00:15 UTC
|
WPM
Wheaton Precious Metals
|
◎ Target | Josh Wolfson ★★★☆☆ #1744 | Outperform | $160.00→ $165.00+3.1% |
|
Sep 17
00:15 UTC
|
WK
Workiva
|
◎ Target | Rob Oliver not yet tracked | Outperform | $95.00→ $105.00+10.5% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.